β-blockers after myocardial infarction and 1-year clinical outcome – a retrospective study

BACKGROUND: Long term β-blocker therapy after myocardial infarction (MI) reduces mortality and recurrent MI but evidence for this treatment predates contemporary acute coronary care. β-blocker treatment is a key quality of care indicator in the Swedish national quality register for acute coronary ca...

Descripción completa

Detalles Bibliográficos
Autores principales: Hagsund, Tora, Olsson, Sven-Erik, Smith, J. Gustav, Madsen Hardig, Bjarne, Wagner, Henrik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7146968/
https://www.ncbi.nlm.nih.gov/pubmed/32272880
http://dx.doi.org/10.1186/s12872-020-01441-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7146968/
https://www.ncbi.nlm.nih.gov/pubmed/32272880
http://dx.doi.org/10.1186/s12872-020-01441-0

Ejemplares similares